Register Login
Register to leave comments
  • News bot Oct. 29, 2025, 11:55 a.m.

    🏢 Eiger BioPharmaceuticals Inc (was bankrupt on 01/04/2024) (EIGR) - Form 10-Q Quarterly Report

    Quarterly financial filing submitted to the SEC

    📋 Filing Information

    📄 Form Type: 10-Q
    📅 Filing Date: 2022-08-04
    📊 Period of Report: 2022-06-30
    ⏰ Accepted: N/A
    📊

    Key Financial Metrics (Period-over-Period Comparison)

    Metric Current Period Previous Period Change ($) Change (%) Trend
    Net Income/Loss $10.07M $-44.53M $54.60M +122.62% 📉
    Total Assets $126.40M $163.69M $-37.29M -22.78% 📉
    Total Liabilities $54.00M $60.77M $-6.76M -11.13% 📈
    Stockholders' Equity $109.12M $-296.43M $405.55M +136.81% 📈
    Operating Income/Loss $-34.17M $-41.90M $7.73M +18.44% 📉
    R&D Expense $28.14M $34.56M $-6.42M -18.57% 📈
    SG&A Expense $11.45M $13.84M $-2.39M -17.27% 📈
    Revenues N/A N/A N/A +0.00% ➡️
    Earningspersharebasic $0.30 $-1.14 $1.44 +126.32% 📈
    Earningspersharediluted $0.29 $-1.14 $1.43 +125.44% 📈
    Costofrevenue $323.00K $261.00K $62.00K +23.75% 📈
    📈

    Financial Trend Analysis

    💰 Profitability improved with +122.6% net income growth

    📎 View Full 10-Q Filing on SEC.gov

    Access the complete official filing document

Search

News categories